369
Views
42
CrossRef citations to date
0
Altmetric
Article

AJUBA LIM Proteins Limit Hippo Activity in Proliferating Cells by Sequestering the Hippo Core Kinase Complex in the Cytosol

, , , , , & show all
Pages 2526-2542 | Received 02 Mar 2016, Accepted 27 Jun 2016, Published online: 17 Mar 2023

REFERENCES

  • Halder G, Johnson RL. 2011. Hippo signaling: growth control and beyond. Development 138:9–22. http://dx.doi.org/10.1242/dev.045500.
  • Harvey KF, Zhang X, Thomas DM. 2013. The Hippo pathway and human cancer. Nat Rev Cancer 13:246–257. http://dx.doi.org/10.1038/nrc3458.
  • Yu FX, Guan KL. 2013. The Hippo pathway: regulators and regulations. Genes Dev 27:355–371. http://dx.doi.org/10.1101/gad.210773.112.
  • Chan EHY, Nousiainen M, Chalamalasetty RB, Schäfer A, Nigg EA, Silljé HHW. 2005. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24:2076–2086. http://dx.doi.org/10.1038/sj.onc.1208445.
  • Bao Y, Sumita K, Kudo T, Withanage K, Nakagawa K, Ikeda M, Ohno K, Wang Y, Hata Y. 2009. Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of Mps 1 binder 1B in the activation of nuclear Dbf2-related kinases. Genes Cells 14:1369–1381. http://dx.doi.org/10.1111/j.1365-2443.2009.01354.x.
  • Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. 2010. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24:72–85. http://dx.doi.org/10.1101/gad.1843810.
  • Ota M, Sasaki H. 2008. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135:4059–4069. http://dx.doi.org/10.1242/dev.027151.
  • Wu S, Liu Y, Zheng Y, Dong J, Pan D. 2008. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell 14:388–398. http://dx.doi.org/10.1016/j.devcel.2008.01.007.
  • Doggett K, Grusche FA, Richardson HE, Brumby AM. 2011. Loss of the Drosophila cell polarity regulator Scribbled promotes epithelial tissue overgrowth and cooperation with oncogenic Ras-Raf through impaired Hippo pathway signaling. BMC Dev Biol 11:57. http://dx.doi.org/10.1186/1471-213X-11-57.
  • Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, Elvassore N, Piccolo S. 2011. Role of YAP/TAZ in mechanotransduction. Nature 474:179–183. http://dx.doi.org/10.1038/nature10137.
  • Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, Zheng P, Ye K, Chinnaiyan A, Halder G, Lai ZC, Guan KL. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21:2747–2761. http://dx.doi.org/10.1101/gad.1602907.
  • Grzeschik NA, Parsons LM, Allott ML, Harvey KF, Richardson HE. 2010. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol 20:573–581. http://dx.doi.org/10.1016/j.cub.2010.01.055.
  • Kim NG, Koh E, Chen X, Gumbiner BM. 2011. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci U S A 108:11930–11935. http://dx.doi.org/10.1073/pnas.1103345108.
  • Zhao B, Li L, Wang L, Wang CY, Yu J, Guan KL. 2012. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 26:54–68. http://dx.doi.org/10.1101/gad.173435.111.
  • Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, Dupont S, Piccolo S. 2013. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154:1047–1059. http://dx.doi.org/10.1016/j.cell.2013.07.042.
  • Ikeda M, Kawata A, Nishikawa M, Tateishi Y, Yamaguchi M, Nakagawa K, Hirabayashi S, Bao Y, Hidaka S, Hirata Y, Hata Y. 2009. Hippo pathway-dependent and -independent roles of RASSF6. Sci Signal 2:ra59. http://dx.doi.org/10.1126/scisignal.2000300.
  • Wehr MC, Holder MV, Gailite I, Saunders RE, Maile TM, Ciirdaeva E, Instrell R, Jiang M, Howell M, Rossner MJ, Tapon N. 2013. Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila. Nat Cell Biol 15:61–71.
  • Liu X, Yang N, Figel SA, Wilson KE, Morrison CD, Gelman IH, Zhang J. 2013. PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene 32:1266–1273. http://dx.doi.org/10.1038/onc.2012.147.
  • Michaloglou C, Lehmann W, Martin T, Delaunay C, Hueber A, Barys L, Niu H, Billy E, Wartmann M, Ito M, Wilson CJ, Digan ME, Bauer A, Voshol H, Christofori G, Sellers WR, Hofmann F, Schmelzle T. 2013. The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity. PLoS One 8:e61916. http://dx.doi.org/10.1371/journal.pone.0061916.
  • Das Thakur M, Feng Y, Jagannathan R, Seppa MJ, Skeath JB, Longmore GD. 2010. Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr Biol 20:657–662. http://dx.doi.org/10.1016/j.cub.2010.02.035.
  • Schimizzi GV, Longmore GD. 2015. Ajuba proteins. Curr Biol 25:R445–R446. http://dx.doi.org/10.1016/j.cub.2015.02.034.
  • Reddy BV, Irvine KD. 2013. Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Dev Cell 24:459–471. http://dx.doi.org/10.1016/j.devcel.2013.01.020.
  • Sun G, Irvine KD. 2013. Ajuba family proteins link JNK to Hippo signaling. Sci Signal 6:ra81. http://dx.doi.org/10.1126/scisignal.2004324.
  • Codelia VA, Sun G, Irvine KD. 2014. Regulation of YAP by mechanical strain through Jnk and Hippo signaling. Curr Biol 24:2012–2017. http://dx.doi.org/10.1016/j.cub.2014.07.034.
  • Rauskolb C, Sun S, Sun G, Pan Y, Irvine KD. 2014. Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex. Cell 158:143–156. http://dx.doi.org/10.1016/j.cell.2014.05.035.
  • Feng Y, Zhao H, Luderer HF, Epple H, Faccio R, Ross FP, Teitelbaum SL, Longmore GD. 2007. The LIM protein, Limd1, regulates AP-1 activation through an interaction with Traf6 to influence osteoclast development. J Biol Chem 282:39–48. http://dx.doi.org/10.1074/jbc.M607399200.
  • Aratyn-Schaus Y, Oakes PW, Stricker J, Winter SP, Gardel ML. 14 December 2010. Preparation of complaint matrices for quantifying cellular contraction. J Vis Exp http://dx.doi.org/10.3791/2173.
  • Tse JR, Engler AJ. 2010. Preparation of hydrogel substrates with tunable mechanical properties. Curr Protoc Cell Biol Chapter 10:Unit 10.16. http://dx.doi.org/10.1002/0471143030.cb1016s47.
  • Meng Z, Moroishi T, Guan KL. 2016. Mechanisms of Hippo pathway regulation. Genes Dev 30:1–17. http://dx.doi.org/10.1101/gad.274027.115.
  • Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, Caroni P. 1998. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393:805–809. http://dx.doi.org/10.1038/31729.
  • Visser S, Yang X. 2010. LATS tumor suppressor: a new governor of cellular homeostasis. Cell Cycle 9:3892–3903. http://dx.doi.org/10.4161/cc.9.19.13386.
  • Reddy BVVG, Irvine KD. 2008. The Fat and Warts signaling pathways: new insights into their regulation, mechanism and conservation. Development 135:2827–2838. http://dx.doi.org/10.1242/dev.020974.
  • Yin F, Yu J, Zheng Y, Chen Q, Zhang N, Pan D. 2013. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 154:1342–1355. http://dx.doi.org/10.1016/j.cell.2013.08.025.
  • Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR, Camargo FD. 2011. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144:782–795. http://dx.doi.org/10.1016/j.cell.2011.02.031.
  • Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD, Lantz DM, Seykora JT, Vasioukhin V. 2011. Alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal 4:ra33. http://dx.doi.org/10.1126/scisignal.2001823.
  • Kanungo J, Pratt SJ, Marie H, Longmore GD. 2000. Ajuba, a cytosolic LIM protein, shuttles into the nucleus and affects embryonal cell proliferation and fate decisions. Mol Biol Cell 11:3299–3313. http://dx.doi.org/10.1091/mbc.11.10.3299.
  • Marie H, Pratt SJ, Betson M, Epple H, Kittler JT, Meek L, Moss SJ, Troyanovsky S, Attwell D, Longmore GD, Braga VM. 2003. The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin. J Biol Chem 278:1220–1228. http://dx.doi.org/10.1074/jbc.M205391200.
  • Hergovich A, Schmitz D, Hemmings BA. 2006. The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem Biophys Res Commun 345:50–58. http://dx.doi.org/10.1016/j.bbrc.2006.03.244.
  • Abe Y, Ohsugi M, Haraguchi K, Fujimoto J, Yamamoto T. 2006. LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis. FEBS Lett 580:782–788. http://dx.doi.org/10.1016/j.febslet.2005.12.096.
  • Arber S, Caroni P. 1996. Specificity of single LIM motifs in targeting and LIM/LIM interactions in situ. Genes Dev 10:289–300. http://dx.doi.org/10.1101/gad.10.3.289.
  • Wada K, Itoga K, Okano T, Yonemura S, Sasaki H. 2011. Hippo pathway regulation by cell morphology and stress fibers. Development 138:3907–3914. http://dx.doi.org/10.1242/dev.070987.
  • Pratt SJ, Epple H, Ward M, Feng Y, Braga VM, Longmore GD. 2005. The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration. J Cell Biol 168:813–824. http://dx.doi.org/10.1083/jcb.200406083.
  • Feng Y, Longmore GD. 2005. The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex. Mol Cell Biol 25:4010–4022. http://dx.doi.org/10.1128/MCB.25.10.4010-4022.2005.
  • Goyal RK, Lin P, Kanungo J, Payne AS, Muslin AJ, Longmore GD. 1999. Ajuba, a novel LIM protein, interacts with Grb2, augments mitogen-activated protein kinase activity in fibroblasts, and promotes meiotic maturation of Xenopus oocytes in a Grb2- and Ras-dependent manner. Mol Cell Biol 19:4379–4389. http://dx.doi.org/10.1128/MCB.19.6.4379.
  • Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. 1995. The Drosophila tumor suppressor gene Warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 9:534–546. http://dx.doi.org/10.1101/gad.9.5.534.
  • Harvey KF, Pfleger CM, Hariharan IK. 2003. The Drosophila Mst ortholog, Hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114:457–467. http://dx.doi.org/10.1016/S0092-8674(03)00557-9.
  • Huang J, Wu S, Barrera J, Matthews K, Pan D. 2005. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122:421–434. http://dx.doi.org/10.1016/j.cell.2005.06.007.
  • Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, Brummelkamp TR. 2007. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17:2054–2060. http://dx.doi.org/10.1016/j.cub.2007.10.039.
  • Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, Lauwers GY, Thasler W, Lee JT, Avruch J, Bardeesy N. 2009. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16:425–438. http://dx.doi.org/10.1016/j.ccr.2009.09.026.
  • Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, Wang Y, Halder G, Finegold MJ, Lee J-S, Johnson RL. 2010. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A 107:1437–1442. http://dx.doi.org/10.1073/pnas.0911427107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.